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Percutaneous (n[56) Surgical (n[59) P-value
B178 J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5Table 1. Patient and Lesion Characteristics and Procedure OutcomesIn-hospital mortality 1.00TFA TRA P ValueSaved 42 (75%) 44 (74.6%)
Patient Characteristics N[117 N[156Age (Mean  SD) 66.612.0 64.712.2 0.20
Death 14 (25.0%) 15 (25.4%)Male Gender (%) 73.5% 73.7% 1.00Length of stay in ICU 23.82  41.12 28.10  25.25 0.50BMI (Mean  SD) 29.75.5 30.96.2 0.10Length of stay in ICU after weaning 16.82  38.53 19.69  21.40 0.62Diabetes Mellitus (%) 48.7% 34.0% 0.02Prior PCI (%) 54.7% 50.0% 0.46
Length of stay in hospital after weaning 42.51  74.33 50.50  89.89 0.61Prior CABG (%) 14.5% 13.5% 0.86Overall complications 8 (14.3%) 7 (11.9%) 0.79Hypertension (%) 88.9% 85.3% 0.47Open repair in insertion site 1 (1.8%) 4 (6.8%) 0.37Hyperlipidemia (%) 90.6% 83.3% 0.11Limb ischemia 2 (3.6%) 3 (5.1%) 1.00
Current Cigarette Smoker – last year (%) 20.5% 30.8% 0.07Cerebral Vascular Disease 9.4% 5.1% 0.23Infection of removal site 0 2 (3.4%) 0.50
Congestive Heart Failure (%) 11.1% 12.8% 0.71Pseudoaneurysm 1 (1.8%) 0 0.49Peripheral Vascular Disease (%) 13.7% 12.8% 0.86Distal part embolization 1 (1.8%) 0 0.49
Lesion Characteristics N[142 N[192Lesion Location - n/N (%) 0.92
Manual compression in weaning site 5 (8.9%) 2 (3.4%) 0.26Left Main 1/142 (0.7%) 1/192 (0.5%)Left Circumﬂex 34/142 (23.9%) 46/192 (24.0%)Left Anterior Descending 64/142 (45.1%) 78/192 (40.6%)Right Coronary 42/142 (29.6%) 64/192 (33.3%)Ramus 1/142 (0.7%) 2/192 (1.0%)ACC/AHA Lesion Classiﬁcation - n/N (%) <0.001A 14/137 (10.2%) 27/189 (14.3%)B1 47/137 (34.3%) 56/189 (29.6%)B2 12/137 (8.8%) 50/189 (26.5%)C 64/137 (46.7%) 56/189 (29.6%)Procedure CharacteristicsNumber of Stents per CorPath
Lesion - Mean  SD (N)
1.10.4 (120) 1.10.4 (178) 1.00Total Contrast Media Volume (ml) -
Mean  SD (N)
186.981.0 (117) 210.1121.0 (156) 0.07Total Fluoroscopy Time (min) -
Mean  SD (N)
15.19.5 (116) 14.26.7 (156) 0.36CONCLUSIONS In this multi-site and multi-operator experience data,
robotic PCI was more commonly done via the radial rather than the
femoral access. Robotic PCI technical success was higher in the TRA
group. Clinical success was high and similar by using either the
femoral or radial access for robotic PCI. These observations support
the concept that trans-radial robotic PCI is feasible and highly
successful.
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BACKGROUND The removal of arterial cannula using a perclose device
has not been reported in patients underwent venoarterial extracorporeal
membrane oxygenation (ECMO). We investigated the procedural outcomes
and complications of percutaneous device closure versus surgical repair for
hemostatic control of the arterial access site in weaning venoarterial ECMO.
METHODS Between September 2012 and December 2014, a total of 115
patients with ECMO weaning by percutaneous or surgical access were
enrolled. The percutaneous technique involved deployment of two
ProGlide devices as a directly puncture to arterial cannula at the time
of weaning off ECMO. The primary outcome was composite compli-
cations of open repair in insertion site, limb ischemia after removal of
arterial cannula, infection of removal site, pseudoaneurysm, distal
part embolization, and manual compression at weaning site.
RESULTS The patients underwent percutaneous and surgical expo-
sure technique were 56 and 59 patients, respectively. There was no
signiﬁcant difference in the rate of technical success between percu-
taneous group and surgical group (85.7% vs. 86.4%, p¼1.0) although
the procedure duration (17.159.38 min vs. 64.3331.67 min; p<0.001)
was shorter in the percutaneous access group. Also, a composite of the
procedure-related complications and length of stay in intensive care
unit after weaning were not signiﬁcantly different between the two
groups (17.9% vs 28.8%, p¼0.19 and 16.8238.53 days vs 19.6921.40
days, p¼0.62, respectively).CONCLUSIONS Percutaneous access using two Perclose ProGlide de-
vice is a feasible and safe strategy for weaning ECMO.
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BACKGROUND Vascular complications remain the most frequent
complication and signiﬁcantly affect the procedural results of TAVI.
METHODS From September 2010 to January 2015, 108 consecutive patients
underwent TAVI in our department. Of them, femoral accesswas obtained in
100 patients, direct aorta in 4 patients and transapical in 4 patients. All 100
patients with femoral access were included to the ﬁnal analysis. Femoral ar-
tery anatomy-tailored programwas introduced in 2013 in our center in order
to reduce the rate of access-site vascular complications in TAVI patients. The
main goal was to ﬁnd an optimal vessel morphology for safe percutaneous
approach. The following angio-CT ﬁndings were considered a high risk for
percutaneous approach: 1. Severe calciﬁcations at thepuncture site 2. Diffuse
atherosclerotic disease with a large plaque burden 3. Inability to perform
contralateral injection- controlled puncture. All patients with such charac-
teristics were pre-planned to surgical cut-down approach. The study cohort
was divided into two subgroups: group A - patients treated between
September 2010 toDecember2012before introductionof the tailoredvascular
access program (n¼35) and group B - patients treated from January 2013 till
December 2014 (n¼65). All patients in group A were treated with percuta-
neous puncture and device closure. Group B comprised of 47 patients with
percutaneous access and 18 patients in whom surgical approach was chosen.
RESULTS A total of 100 patients (mean age 79.66.5, range 57 to 91, 46%
male) with femoral access were included to the analysis. The CoreValve
prosthesiswas implanted in95patents (95%)andLotus in4patients (4%). In
one case the prosthesis was not implanted because the patient died during
procedure after wire positioning. In one patient with Prostar closure the
device could not be successfully closed and the artery was closed in the
surgical manner. Vascular access site complication rate signiﬁcantly
decreased from 34,3% in the group A (n¼12) to 6,2% in the group B (n¼4)
(p¼0,0005).Bothminorandmajor accesscomplicationsweremore frequent
in the groupA than in the groupB, and the resultwas statistically signiﬁcant
(p¼0,03 and 0,02, respectively). Both groups did not differmuch in terms of
baseline characteristics and risk evaluated on the basis of risk score calcu-
lators. Arterial hypertension and prior myocardial infarction were more
common in thegroupB. In-hospitalmortalitywas 11,4%(n¼4) in thegroupA
and 1,5% (n¼1) in the group B (p¼0,05). Two deaths were related to access
site complications in the group A, one in the group B.
CONCLUSIONS The introduction of tailored vascular access program
resulted in signiﬁcant reduction in both minor and access site com-
plications. The pre-procedural access screening with qualiﬁcation to
closure-device or surgical cutdown technique seems to be the most
important step to reduce the vascular complication rate.
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